We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.24%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.4B
Cap. Flow
% of AUM
-14.12%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,549
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$301M |
| 2 |
Estee Lauder
EL
|
+$252M |
| 3 |
Boeing
BA
|
+$251M |
| 4 |
Kenvue
KVUE
|
+$174M |
| 5 |
Fidelity National Information Services
FIS
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$547M |
| 2 |
Union Pacific
UNP
|
+$459M |
| 3 |
Pinnacle West Capital
PNW
|
+$203M |
| 4 |
Wells Fargo
WFC
|
+$199M |
| 5 |
Bank of America
BAC
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.36% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Ultragenyx Pharmaceutical
RARE
$2.55B
| $123K | ﹤0.01% |
3,490
+1,900
| +119% | +$75.3K |
|
1352
Atlas Energy Solutions
AESI
$1.41B
| $122K | ﹤0.01% |
+5,537
| New | +$116K |
|
|
BRY
1353
DELISTED
Berry Corp
BRY
| $122K | ﹤0.01% |
15,045
+5,115
| +52% | +$41K |
|
|
EEX
1354
DELISTED
Emerald Holding
EEX
| $122K | ﹤0.01% |
27,200
+7,350
| +37% | +$31.1K |
|
|
SJT
1355
San Juan Basin Royalty Trust
SJT
$118M
| $122K | ﹤0.01% |
17,730
+2,413
| +16% | +$17.4K |
|
1356
Quest Diagnostics
DGX
$26.3B
| $121K | ﹤0.01% |
1,001
-107
| -10% | -$14.3K |
|
1357
NETSCOUT
NTCT
$2.79B
| $121K | ﹤0.01% |
4,326
+3,135
| +263% | +$89.7K |
|
1358
Sylvamo
SLVM
$1.63B
| $121K | ﹤0.01% |
2,771
+1,374
| +98% | +$59.1K |
|
1359
iShares MSCI Turkey ETF
TUR
$213M
| $121K | ﹤0.01% |
+3,145
| New | +$110K |
|
1360
PTC Therapeutics
PTCT
$6.12B
| $120K | ﹤0.01% |
5,400
+1,063
| +25% | +$39.5K |
|
|
CLDT
1361
Chatham Lodging
CLDT
$586M
| $119K | ﹤0.01% |
+12,460
| New | +$119K |
|
|
RPTX
1362
DELISTED
Repare Therapeutics
RPTX
| $119K | ﹤0.01% |
9,878
+7,136
| +260% | +$73.7K |
|
1363
Cricut
CRCT
$1.22B
| $118K | ﹤0.01% |
+12,714
| New | +$134K |
|
|
FBRT
1364
Franklin BSP Realty Trust
FBRT
$657M
| $118K | ﹤0.01% |
8,934
+1,121
| +14% | +$15.6K |
|
1365
V2X
VVX
$2.65B
| $118K | ﹤0.01% |
2,286
+411
| +22% | +$20.7K |
|
1366
Weyco Group
WEYS
$440M
| $118K | ﹤0.01% |
4,673
+1,221
| +35% | +$32.4K |
|
1367
Xerox
XRX
$425M
| $118K | ﹤0.01% |
7,571
+3,335
| +79% | +$52.7K |
|
|
GTLS.PRB
1368
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $117K | ﹤0.01% |
+1,760
| New | +$118K |
|
1369
Palomar
PLMR
$3.45B
| $117K | ﹤0.01% |
2,306
+1,500
| +186% | +$82K |
|
|
SBR
1370
Sabine Royalty Trust
SBR
$1.05B
| $117K | ﹤0.01% |
1,788
+146
| +9% | +$9.59K |
|
1371
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
| $117K | ﹤0.01% |
550
| – | – |
|
|
ZIMV
1372
DELISTED
ZimVie
ZIMV
| $117K | ﹤0.01% |
12,537
+1,475
| +13% | +$17K |
|
|
XYZ
1373
Block Inc
XYZ
$47.5B
| $117K | ﹤0.01% |
2,669
-329
| -11% | -$20.4K |
|
1374
ACM Research
ACMR
$5.79B
| $116K | ﹤0.01% |
+6,436
| New | +$95.7K |
|
1375
Cooper-Standard Automotive
CPS
$558M
| $116K | ﹤0.01% |
+8,698
| New | +$138K |
|
Similar funds
QCM
Lazard Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Lazard Asset Management held 2,549 positions worth $73.5B, down 9.5% from $81.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $10.4B in Q3 2023, closing 243 positions and reducing 712 holdings. Its most notable exit was Littelfuse, an estimated $24.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in ScottsMiracle-Gro worth $28.3M.
- Lazard Asset Management's largest Q3 2023 buy was ScottsMiracle-Gro: 548,310 shares worth $28.3M.
- Lazard Asset Management added most to PPL Corp in Q3 2023, an estimated $301M increase.
- Lazard Asset Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $547M.
- Lazard Asset Management fully exited Littelfuse in Q3 2023, selling an estimated $24.3M.
- Lazard Asset Management's ten largest holdings make up 24% of its $73.5B portfolio in Q3 2023.
- Lazard Asset Management opened 227 new positions and closed 243 in Q3 2023.
- Lazard Asset Management's portfolio value fell 9.5% quarter-over-quarter to $73.5B.
Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.